Form 4: Organogenesis Holdings Inc. Executive Reports Stock Disposals to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Robert Cavorsi, Vice President of Strategy at Organogenesis Holdings Inc., disposed of shares to cover tax obligations arising from vested stock.

Summary

  • On March 9, 2025, Robert Cavorsi, Vice President of Strategy at Organogenesis Holdings Inc., disposed of shares of Class A Common Stock to cover tax obligations.
  • The transactions involved the disposal of 210 shares and 61 shares at a price of $5.16 per share.
  • Following these transactions, Cavorsi directly owns 189,525 shares of Class A Common Stock.
  • The transactions were reported on Form 4, filed with the Securities and Exchange Commission on March 12, 2025.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock disposals for tax purposes, which is neutral in sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

  • The stock disposal may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates

DateDescription
03/09/2025Date of stock disposal transactions
03/12/2025Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.